Argatroban
Brand names,
Argatroban
Analogs
Argatroban
Brand Names Mixture
Argatroban
Chemical_Formula
C23H36N6O5S
Argatroban
RX_link
http://www.rxlist.com/cgi/generic2/argatroban.htm
Argatroban
fda sheet
Argatroban
msds (material safety sheet)
Argatroban
Synthesis Reference
No information avaliable
Argatroban
Molecular Weight
508.635 g/mol
Argatroban
Melting Point
No information avaliable
Argatroban
H2O Solubility
No information avaliable
Argatroban
State
Solid
Argatroban
LogP
0.749
Argatroban
Dosage Forms
Solution
Argatroban
Indication
For prophylaxis or treatment of thrombosis in patients with heparin-induced thrombocytopenia
Argatroban
Pharmacology
Argatroban is a synthetic direct thrombin inhibitor derived from L-arginine indicated as an anticoagulant for prophylaxis or treatment of thrombosis in patients with heparin-induced thrombocytopenia. Argatroban is a direct thrombin inhibitor that reversibly binds to the thrombin active site. Argatroban does not require the co-factor antithrombin III for antithrombotic activity. Argatroban exerts its anticoagulant effects by inhibiting thrombin-catalyzed or -induced reactions, including fibrin formation; activation of coagulation factors V, VIII, and XIII; protein C; and platelet aggregation. Argatroban is highly selective for thrombin with an inhibitory constant (Ki) of 0.04 µM. At therapeutic concentrations, Argatroban has little or no effect on related serine proteases (trypsin, factor Xa, plasmin, and kallikrein).
Argatroban
Absorption
No information avaliable
Argatroban
side effects and Toxicity
No information avaliable
Argatroban
Patient Information
No information avaliable
Argatroban
Organisms Affected
Humans and other mammals